Last reviewed · How we verify
NCT04242680
tRNS Combined to Cognitive Training in Children With Dyscalculia
NA trial testing Brainstim DLPFC in Developmental Dyscalculia in 102 participants. Status unknown.
5 January 2024
Quick facts
| Lead sponsor | Bambino Gesù Hospital and Research Institute |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 102 |
| Start date | 2 September 2019 |
| Primary completion | 5 January 2024 |
| Estimated completion | 5 May 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Brainstim DLPFC
- Brainstim PPC
- Brainstim Sham
- Cognitive Training
Conditions studied
- Developmental Dyscalculia — all drugs for Developmental Dyscalculia →
Sponsor
Bambino Gesù Hospital and Research Institute
Who can join
Adults 8 to 14, any sex, with Developmental Dyscalculia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study grounds on the absence of evidence-based treatment in individuals with developmental dyscalculia (DD). At this topic, the present study will explore the potential effect of transcranial random noise stimulation (tRNS) over dorsolateral prefrontal cortex (DLPFC) or posterior parietal cortex (PPC), cerebral areas usually disrupted in individuals with DD, in addition to a usual treatment such as cognitive training. Therefore, the investigators hypothesized that active tRNS over DLPFC or PPC combined to cognitive training will boost math and math-related skills in children and adolescents with DD, modulating theta/beta ratio around stimulated cerebral network. On the contrary, sham tRNS (placebo) over DLPFC or PPC combined to cognitive training will not have significant effect in improving math skills. Further, both active and sham tRNS combined to cognitive training will be safe and well tolerated.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Examining tolerability, safety, and blinding in 1032 transcranial electrical stimulation sessions for children and adolescents with neuropsychiatric and neurodevelopmental disorders.
Battisti A, Lazzaro G, Ursumando L, D'Aiello B, et al · · 2025 · cited 5× · PMID 39915614 · DOI 10.1038/s41598-025-88256-1 -
Boosting Numerical Cognition in Children and Adolescents with Mathematical Learning Disabilities by a Brain-Based Intervention: A Study Protocol for a Randomized, Sham-Controlled Clinical Trial.
Lazzaro G, Battisti A, Varuzza C, Celestini L, et al · · 2021 · cited 3× · PMID 34682715 · DOI 10.3390/ijerph182010969
Verify or expand the search:
- PubMed search for NCT04242680
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Bambino Gesù Hospital and Research Institute trials
Trials by the same sponsor.
- NCT07297914 — Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL · Phase 2, PHASE3 · not yet recruiting
- NCT07464561 — RESCCUE4 - Group CBT for Social Anxiety in Adolescents · NA · completed
- NCT06080191 — Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL · Phase 1 · recruiting
- NCT06064903 — CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL · Phase 1, PHASE2 · recruiting
- NCT06931730 — Reprogramming Energy Homeostasis in Overweight Individuals Via Exercise, Cognitive, and Social Training · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04242680 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bambino Gesù Hospital and Research Institute
- Last refreshed: 10 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04242680.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing